Mitsubishi UFJ Asset Management
BNGO icon

Mitsubishi UFJ Asset Management’s Bionano Genomics BNGO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,901
Closed -$1.07M – 1566
2023
Q3 		$1.07M Sell
5,901
-81
-1% -$21.2K ﹤0.01% 804
2023
Q2 		$2.19M Buy
5,982
+4,230
+241% +$1.91M ﹤0.01% 730
2023
Q1 		$1.17M Buy
1,752
+47
+3% +$41.7K ﹤0.01% 792
2022
Q4 		$1.47M Sell
1,705
-810
-32% -$1.02M ﹤0.01% 755
2022
Q3 		$2.76M Sell
2,515
-18
-0.7% -$23.8K 0.01% 648
2022
Q2 		$2.1M Buy
2,533
+794
+46% +$817K 0.01% 695
2022
Q1 		$2.69M Sell
1,739
-63
-3% -$85K 0.01% 676
2021
Q4 		$3.49M Sell
1,802
-38
-2% -$102K 0.01% 648
2021
Q3 		$6.07M Sell
1,840
-103
-5% -$360K 0.03% 520
2021
Q2 		$8.54M Buy
+1,943
New +$7.67M 0.05% 418

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mitsubishi UFJ Asset Management's BNGO Position: Q4 2023 in Review

Mitsubishi UFJ Asset Management sold out of Bionano Genomics (BNGO) in Q4 2023, closing a stake of 5,901 shares — an estimated $1.07M sold.

Mitsubishi UFJ Asset Management first reported a position in BNGO in Q2 2021 and held it in 10 quarters. The position peaked at $8.54M in Q2 2021. 62 funds tracked by Wall St. Rank hold BNGO as of Q4 2023.

  • Mitsubishi UFJ Asset Management reported no remaining Bionano Genomics position as of Q4 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 5,901 Bionano Genomics shares in Q4 2023, an estimated $1.07M.
  • Mitsubishi UFJ Asset Management first reported a position in Bionano Genomics in Q2 2021 and held it in 10 quarters.
  • Mitsubishi UFJ Asset Management's Bionano Genomics position peaked at $8.54M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.